Evolus Inc
EOLS
$7.84-0.89%
End of day · as of Sep 14, 2026, 1:00 AM ET
Mkt cap
$597.04M
EV/Sales
2.32
P/E ratio
N/A
FY2025 Revenue
$297.18M
EPS (TTM)
$-0.53
Gross Margin (FY2025)
66.33%
Profit Margin (FY2025)
-17.38%
Beta
0.99
Div yield
N/A
Sector
Healthcare
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported EOLS revenue for 2025-12-31 was $297.2M. Net income was -$51.6M. Revenue was up 11.6% from 2024-12-31 to 2025-12-31. EOLS currently screens at market cap $597.0M.
Use this EOLS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full EOLS income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Evolus Inc (EOLS) revenue for Dec 31, 2025 was $297.2M. Net income was -$51.6M. Statements: https://lician.com/financials/eols
Evolus Inc (EOLS) market capitalization is $597.0M on the latest cached snapshot.
Evolus Inc (EOLS) cached previous close $7.91; day range $7.81 – $8.15; volume 586,132. Session quote: https://lician.com/quote/eols
Evolus Inc (EOLS) latest cached earnings event is "EOLS earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached EOLS filing is 8-K · Aug 4, 2026. Filings: https://lician.com/sec/eols